• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

7 medtech advances to improve diabetes treatment

January 10, 2020 By Sean Whooley

[Image from National Institutes of Health]

1. Tandem closed-loop controller

Tandem Diabetes Care (NSDQ:TNDM) just last month received FDA clearance for its t:slim X2 insulin pump and Control-IQ advanced hybrid closed-loop technology to control Type 1 diabetes.

The Tandem system uses continuous glucose monitoring (CGM) values, in conjunction with other variables such as insulin on board, to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly, the company said. Control-IQ technology also offers optional settings for sleep and exercise that will change the treatment values to better match the different physiologic needs during these activities.

The t:slim X2 insulin pump also received an ACE infusion pump classification in February 2019, becoming the first device of its kind to do so. It is touted as the first insulin pump designated as compatible with iCGM devices, too.

Other companies like Medtronic (NYSE:MDT) have closed-loop insulin pump systems as well, as the device — often referred to as an “artificial pancreas” — is one of many that could bring diabetes treatment even further along.

Next>>

Pages: Page 1 Page 2

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Technology Tagged With: dariohealth, FDA, Medtronic, Novo Nordisk, One Drop, optiscanbiomedical, popsdiabetescare, Senseonics, Tandem Diabetes Care, Valeritas Inc.

IN CASE YOU MISSED IT

  • TerSera touts study results of infusion reaction prevention treatment
  • Cannabinoid treatment developer SciSparc raises $8.15M
  • Senseonics sinks on mixed bag Q4, massive bottom-line slide
  • Pulmatrix completes $40M offering, updates product pipeline timetable
  • Amgen to acquire Five Prime Therapeutics for $1.9B

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS